GO:0017148 negative regulation of translation: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017148 negative regulation of translation describes any process that stops, prevents, or reduces the frequency, rate, or extent of protein synthesis from mRNA or circRNA.
• Translation is most often controlled at the initiation step, where phosphorylation of eIF2alpha by stress kinases such as PERK and GCN2 globally suppresses protein synthesis while selectively increasing translation of stress-responsive mRNAs.
• Elongation-phase control, including eEF2 phosphorylation and codon-biased decoding, fine-tunes translation accuracy and can influence lifespan and cancer metabolism.
• m6A mRNA modification can switch transcripts from polysomes to P-bodies via IGF2BP3, providing a transcript-specific mechanism of negative regulation.
• Negative regulation of translation is central to hypoxia adaptation, PI3K/PTEN pathway homeostasis, maternal-to-embryonic transition, and plant uORF-based control.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of translation-control genes in disease and development.
Description
Negative regulation of translation (GO:0017148) is a biological process that stops, prevents, or reduces the frequency, rate, or extent of protein synthesis from mRNA or circRNA. Because translation consumes a large fraction of cellular energy and determines the proteome, its negative control is essential for homeostasis, stress adaptation, and developmental transitions. Researchers study this term to understand how cells globally repress protein synthesis under stress while selectively translating specific mRNAs, and how dysregulation contributes to cancer, metabolic disease, and developmental disorders. The process operates at multiple levels, including initiation, elongation, mRNA modification, and transcript sequestration, and is mediated by a defined set of translation factors, kinases, RNA-binding proteins, and signaling pathways.
negative regulation of translation At A Glance
| GO ID | GO:0017148 |
|---|---|
| GO term | negative regulation of translation |
| Ontology | biological_process |
| Synonym | down regulation of protein biosynthetic process; inhibition of protein biosynthetic process; negative regulation of protein synthesis; protein biosynthesis inhibitor activity |
| Major function | Reduces the frequency, rate, or extent of protein synthesis from mRNA or circRNA |
| Key regulatory nodes | eIF2alpha kinases (PERK, GCN2), eIF4E/4E-BP, eEF2 kinase, m6A/IGF2BP3, uORFs |
| Representative pathways | Integrated stress response, mTORC1 signaling, hypoxia response, PI3K/PTEN homeostasis |
| Disease relevance | Cancer, metabolic disorders, neurodegeneration, developmental defects |
What Is GO:0017148?
In our own words, GO:0017148 negative regulation of translation encompasses any cellular mechanism that reduces the rate or extent of protein biosynthesis from mRNA or circRNA. This includes global translational shutdown during stress, transcript-specific repression by RNA-binding proteins or microRNAs, sequestration of mRNAs into P-bodies, and inhibition of initiation or elongation factors.
Why Is negative regulation of translation Important in Cell Biology?
Negative regulation of translation is a fundamental control layer that allows cells to rapidly reprogram gene expression without changing mRNA levels. It is essential for surviving stress, maintaining proteostasis, and executing developmental programs, and its dysfunction is linked to cancer, metabolic disease, and developmental disorders.
• Enables rapid, energy-efficient reprogramming of the proteome during stress.
• Controls the integrated stress response and cell survival decisions.
• Regulates hypoxia adaptation by suppressing global translation while favoring HIF-1alpha translation.
• Maintains PI3K/PTEN pathway homeostasis through feedback control of PTEN translation.
• Drives maternal-to-embryonic transition by regulating eIF4E availability.
• Modulates lifespan and translation accuracy via elongation-phase control.
• Links m6A RNA modification to transcript-specific translational repression.
• Provides a mechanism for codon-biased translation in cancer metabolism.
• Is exploited by plants via uORFs to control translation under stress.
• Offers therapeutic targets for cancer, metabolic disease, and neurodegeneration.
What Happens During negative regulation of translation?
Initiation-phase repression
In simple terms: The cell blocks the first step of protein synthesis, so most mRNAs cannot be translated.
Initiation is the rate-limiting step of translation and the primary target of negative regulation. Phosphorylation of eIF2alpha by stress-activated kinases such as PERK and GCN2 inhibits ternary complex formation, globally reducing translation initiation while paradoxically enhancing translation of upstream ORF-containing mRNAs like ATF4. Similarly, hypoxia suppresses global translation initiation while maintaining or enhancing translation of specific mRNAs such as HIF-1alpha. In plants, upstream open reading frames in leader sequences mediate translational repression in response to stress.
Elongation-phase control
In simple terms: The cell slows down the protein assembly line after it has already started.
Negative regulation also occurs during elongation. Phosphorylation of eEF2 by eEF2 kinase reduces the rate of translocation, and modulating elongation can enhance translation accuracy and influence lifespan in model organisms. Codon-biased translation, regulated by tRNA modifications such as NSUN2-dependent tRNA(Val-CAC) methylation, can selectively reduce translation of specific codon-enriched mRNAs in cancer.
mRNA modification and sequestration
In simple terms: Chemical tags on mRNA can send the transcript to storage compartments, preventing it from being translated.
N6-methyladenosine (m6A) modification of mRNA can negatively regulate translation by switching transcripts from polysomes to P-bodies in an IGF2BP3-dependent manner. This provides a transcript-specific mechanism to repress translation without degrading the mRNA, allowing rapid re-activation when conditions change.
Signaling integration by mTORC1 and PI3K
In simple terms: Growth signals tell the cell whether to make proteins or hold back.
mTORC1 promotes translation by phosphorylating 4E-BP and S6K, so inhibition of mTORC1 relieves repression of 4E-BP and reduces cap-dependent translation. PI3K signaling also controls PTEN translation to maintain pathway homeostasis, illustrating feedback between translation and growth signaling. These pathways integrate nutrient, energy, and growth factor cues to set the translational output.
Developmental and maternal-to-embryonic control
In simple terms: Early embryos must silence maternal mRNAs and start new protein programs at the right time.
Eukaryotic translation initiation factor 4E (eIF4E) regulates the mammalian maternal-to-embryonic transition, and its negative regulation is required for proper developmental timing. This highlights how translational repression is not merely a stress response but a core developmental mechanism.
Key Genes Involved in GO:0017148 negative regulation of translation
The following genes and proteins are central to negative regulation of translation, spanning initiation, elongation, RNA modification, and signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF2AK3 (PERK) | Phosphorylates eIF2alpha to repress global translation during ER stress | Integrated stress response, cancer, neurodegeneration |
| EIF2AK4 (GCN2) | Phosphorylates eIF2alpha in response to amino acid deprivation | Metabolic stress, immune regulation |
| EIF2S1 (eIF2alpha) | Target of phosphorylation that inhibits ternary complex formation | Core node of translational repression |
| EIF4E | Cap-binding subunit; availability controls initiation | Maternal-to-embryonic transition, cancer |
| EIF4EBP1 (4E-BP1) | Binds eIF4E to inhibit cap-dependent translation | mTORC1 readout, cancer metabolism |
| EEF2K | Phosphorylates eEF2 to slow elongation | Lifespan, synaptic plasticity |
| IGF2BP3 | Recognizes m6A to shift mRNA to P-bodies | Cancer, RNA modification |
| METTL3 | m6A writer that can mark mRNAs for translational repression | Epitranscriptomics, cancer |
| PTEN | Its translation is feedback-regulated by PI3K signaling | Cancer, PI3K pathway homeostasis |
| HIF1A | Its translation is maintained under hypoxia despite global repression | Hypoxia adaptation, cancer |
| ATF4 | Preferentially translated when eIF2alpha is phosphorylated | Stress response, metabolism |
| NSUN2 | tRNA methyltransferase affecting codon-biased translation | Cancer metabolism |
| DDX3X | RNA helicase involved in translation and stress granules | Cancer, neurodevelopment |
| G3BP1 | Stress granule nucleator that sequesters mRNAs | Stress response, neurodegeneration |
| TIA1 | Stress granule protein linked to translational repression | Neurodegeneration, RNA biology |
| PABPC1 | Poly(A)-binding protein influencing translation and stability | Global translation control |
| RPS6KB1 (S6K1) | mTORC1 effector promoting translation initiation | Growth signaling, cancer |
How Is negative regulation of translation Regulated?
Negative regulation of translation is itself tightly regulated by signaling pathways. The integrated stress response, driven by eIF2alpha kinases such as PERK and GCN2, couples translational repression to amino acid availability, ER stress, and viral infection. mTORC1 controls the phosphorylation of 4E-BP and S6K, thereby gating cap-dependent initiation. Hypoxia suppresses global translation while maintaining translation of HIF-1alpha, integrating oxygen sensing with translational control. In plants, uORFs mediate translational repression in response to developmental and environmental cues. These layers allow precise, reversible control of protein synthesis.
negative regulation of translation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF2AK3 (PERK) | ER stress-related neurodegeneration and diabetes | Knockout and point-mutation cell models |
| EIF4EBP1 | Cancer metabolism and mTORC1-driven growth | Knockout and overexpression models |
| IGF2BP3 | m6A-dependent cancer progression | Knockout and tagged knock-in for RNA binding |
| NSUN2 | Triple-negative breast cancer glycolysis | Knockout and point-mutation models |
| EIF4E | Developmental defects and cancer | Knock-in and overexpression models |
Cancer
Dysregulated translation supports oncogenic growth, and negative regulators such as 4E-BP1 and eIF2alpha kinases are frequently altered in tumors. m6A-dependent translational repression via IGF2BP3 can be subverted in cancer to promote proliferation. Codon-biased translation driven by NSUN2-tRNA(Val-CAC) supports triple-negative breast cancer glycolysis and progression. PTEN translation is feedback-controlled by PI3K signaling, and its loss amplifies oncogenic signaling.
Metabolic and stress-related disorders
The integrated stress response, mediated by eIF2alpha phosphorylation, is implicated in metabolic dysfunction and neurodegeneration. Elongation-phase control can modulate lifespan and translation accuracy, linking translational fidelity to aging. Hypoxia-driven translational reprogramming contributes to ischemic and metabolic pathologies.
Developmental disorders
eIF4E-dependent regulation of the maternal-to-embryonic transition is essential for early development, and its disruption can cause embryonic lethality or developmental defects. Plant uORF-mediated translational control illustrates how conserved this regulatory logic is across kingdoms.
From negative regulation of translation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a translation repressor increase global protein synthesis? | CRISPR knockout cell line with polysome profiling |
| Does a specific phosphorylation site control translational repression? | Point-mutation knock-in of phospho-dead or phospho-mimetic alleles |
| Where does a repressor bind target mRNAs? | Tagged knock-in for CLIP or RIP |
| Does overexpression of a repressor reduce tumor growth? | Doxycycline-inducible overexpression xenograft |
| Which mRNAs escape global repression? | Knockout plus Ribo-seq and RNA-seq |
| Does a repressor control developmental timing? | Knockout and rescue in embryonic stem cells |
How to Study the negative regulation of translation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and translation efficiency | Global and transcript-specific repression |
| Polysome profiling | Distribution of mRNAs across polysomes | m6A-mediated polysome-to-P-body switch |
| Phospho-immunoblot | Phosphorylation of eIF2alpha, eEF2 | Stress-induced translational repression |
| Proteomics | Protein abundance changes | Proteome reprogramming |
| RNA-seq | mRNA levels and splicing | Distinguishing transcription from translation |
| CLIP/RIP | RNA binding sites of repressors | Target identification for IGF2BP3 |
| Fluorescence microscopy | Stress granule and P-body formation | mRNA sequestration |
| Polysome-associated mRNA sequencing | Translatome composition | Selective translation under stress |
Ribosome profiling (Ribo-seq)
Ribo-seq measures ribosome occupancy transcriptome-wide and is the gold standard for quantifying changes in translation efficiency upon negative regulation. It can reveal selective translation of stress-responsive mRNAs such as ATF4 when eIF2alpha is phosphorylated.
Polysome profiling
Sucrose gradient polysome profiling separates actively translated mRNAs from untranslated pools, allowing assessment of global translational repression and mRNA sequestration into P-bodies.
Proteomics and phosphoproteomics
Mass spectrometry quantifies protein output and phosphorylation of translation factors such as eIF2alpha and eEF2, linking signaling to translational repression.
Imaging of stress granules and P-bodies
Fluorescence microscopy of G3BP1, TIA1, and P-body markers visualizes mRNA sequestration, a hallmark of negative regulation of translation.
How CRISPR Can Be Used to Study GO:0017148 negative regulation of translation
Knockout
CRISPR knockout of translation repressors such as EIF4EBP1 or EIF2AK3 removes negative regulation, increasing global or transcript-specific translation. Knockout cell models combined with Ribo-seq reveal which mRNAs depend on each repressor.
Point Mutation
Point-mutation knock-in of phospho-dead or phospho-mimetic residues in eIF2alpha or eEF2K allows precise dissection of phosphorylation-dependent translational control without confounding expression changes.
Knock-in
Tagged knock-in of IGF2BP3 or G3BP1 enables RNA immunoprecipitation and imaging of repressor-mRNA complexes in their native genomic context.
Overexpression
Inducible overexpression of negative regulators such as 4E-BP1 or PTEN can suppress translation and reduce oncogenic growth, providing gain-of-function evidence for causal roles.
How EDITGENE Supports negative regulation of translation Research
Researchers studying negative regulation of translation-related genes often need to determine whether a candidate gene is causally involved in translational control, and whether a specific domain, phosphorylation site, or RNA-binding residue is required. EDITGENE provides publication-ready CRISPR cell models and screening services to answer these questions with rigor.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of translation research.
Frequently Asked Questions About negative regulation of translation
What is negative regulation of translation (GO:0017148)?
It is any process that stops, prevents, or reduces the frequency, rate, or extent of protein synthesis from mRNA or circRNA.
What genes are involved in negative regulation of translation?
Key genes include EIF2AK3 (PERK), EIF2AK4 (GCN2), EIF2S1, EIF4EBP1, EEF2K, IGF2BP3, METTL3, and NSUN2.
How does eIF2alpha phosphorylation inhibit translation?
Phosphorylated eIF2alpha inhibits ternary complex formation, reducing initiation of most mRNAs while allowing selective translation of ATF4.
What is the role of m6A in translational repression?
m6A modification can switch mRNAs from polysomes to P-bodies via IGF2BP3, repressing translation without degrading the transcript.
How is translation regulated under hypoxia?
Hypoxia suppresses global translation initiation while maintaining translation of HIF-1alpha and other stress-responsive mRNAs.
What is the integrated stress response?
It is a signaling program driven by eIF2alpha kinases that globally represses translation while selectively inducing stress genes.
Can CRISPR knockout be used to study translation repressors?
Yes, knockout of repressors such as 4E-BP1 or PERK increases translation and reveals transcript-specific dependencies.
What methods measure negative regulation of translation?
Ribo-seq, polysome profiling, phospho-immunoblot, proteomics, and imaging of stress granules are commonly used.
Why is negative regulation of translation important in cancer?
It supports metabolic adaptation and oncogenic growth, and its dysregulation is linked to tumor progression.
How does eIF4E control early development?
eIF4E availability regulates the maternal-to-embryonic transition, and its negative regulation is required for proper developmental timing.
Conclusion
GO:0017148 negative regulation of translation is a central biological process that controls protein synthesis at initiation, elongation, and mRNA sequestration levels. Its dysregulation contributes to cancer, metabolic disease, and developmental disorders, making it a high-value target for mechanistic and therapeutic research. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with Ribo-seq and proteomics, provide the tools needed to dissect this process with precision.
References
- 1. Mukherjee R et al.. 2021. Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis.. Mol Cell 81(4):708-723.e5 PMID: 33606974
- 2. Harding HP et al.. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells.. Mol Cell 6(5):1099-108 PMID: 11106749
- 3. Wang W et al.. 2025. NSUN2-tRNA(Val-CAC)-axis-regulated codon-biased translation drives triple-negative breast cancer glycolysis and progression.. Cell Mol Biol Lett 30(1):100 PMID: 40855521
- 4. Li Y et al.. 2021. Regulation of the mammalian maternal-to-embryonic transition by eukaryotic translation initiation factor 4E.. Development 148(12) PMID: 34013332
- 5. Xie J et al.. 2019. Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan.. Curr Biol 29(5):737-749.e5 PMID: 30773367
- 6. Shan T et al.. 2023. m(6)A modification negatively regulates translation by switching mRNA from polysome to P-body via IGF2BP3.. Mol Cell 83(24):4494-4508.e6 PMID: 38016476
- 7. von Arnim AG et al.. 2014. Regulation of plant translation by upstream open reading frames.. Plant Sci 214:1-12 PMID: 24268158
- 8. Wouters BG et al.. 2005. Control of the hypoxic response through regulation of mRNA translation.. Semin Cell Dev Biol 16(4-5):487-501 PMID: 15896987
